US 11447541
Anti-coronavirus antibodies and methods of use
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11447541 (Anti-coronavirus antibodies and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Svcs. expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Svcs.
- Grant date
- Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K39/215